
European Journal of Medicinal Chemistry p. 309 - 316 (1994)
Update date:2022-09-26
Topics:
Harraga, S.
Nicod, L.
Drouhin, J. P.
Xicluna, A.
Panouse, J. J.
et al.
About 40 substituted imidazo<2,1-b>thiazoles were obtained in order to study their in vitro immunological effect on the modulation of the expression of human T trypsinized lymphocytes by the CD2 receptor.A synthetic program was developed to introduce either an oxygenated function, such as ester (11, 14), acid (12) and arylketonic groups (9, 13, 15), or two groups, such as an aryl and an ester (1, 6, 8), an acid (3, 7) or a hydrazide (2).These compounds were examined by an E-rosette-forming-cell test, and display a positive drug efficacity index, suggesting a regeneration effect on the expression of CD2 receptors.The following structural parameters are favourable: an aryl moiety on the C-6 with a methoxy or nitro group: and an ethyl ester on the C-3, a double bond to the 2,3-position (the 5,6-position is ineffective).Acid and hydrazide functions or the loss of phenyl group on the C-6 decrease this activity.If the aryl group is on the C-3 or C-2 side chain, the activity is weaker and more so for the latter.However, the most interesting derivatives are less immunostimulating than levamisole hydrochloride. immunomodulator / imidazo<2,1-b>thiazole / human T lymphocyte / CD2 receptor
View MoreLonzeal Pharmaceuticals Co., Ltd.
website:http://www.lonzeal.com
Contact:+86-13381011962
Address:RM 801, Yue MOMA, No. 26 Anningzhuang Rd. Haidian District, Beijing, China
Evergreen Chemical Industry Ltd.
Contact:86-553-4918210
Address:6#2-602 Wanhaobailing
Contact:+86-519-86339586,13584329896
Address:Changzhou Scientific and Education Park
Allright GC (Jinan) Biotechnology Ltd.
website:https://www.argcbiotech.com/
Contact:86-18405413579-
Address: No.27566 of Jingshiroad, Huaiyin District, Jinan City(250011), Shandong Province, China.
Jiangxi Dongbang Pharmaceutical Co., Ltd.
Contact:+86-795-4433603, 4433388
Address:Fengxin Industrial Park, Fengxin County, Jiangxi Province, P.R.C
Doi:10.1007/BF00510023
()Doi:10.1039/c2ob26754c
(2013)Doi:10.1016/S0020-1693(00)00387-X
(2001)Doi:10.1021/om001035a
(2001)Doi:10.1016/j.carres.2009.10.007
(2010)Doi:10.1021/ol015965h
(2001)